IL6 receptor358Ala variant and trans-signaling are disease modifiers in amyotrophic lateral sclerosis
Citation Manager Formats
Make Comment
See Comments

In the article “IL6 receptor358Ala variant and trans-signaling are disease modifiers in amyotrophic lateral sclerosis” by Wosiski-Kuhn et al.,1 first published online October 14, 2019, the y-axis label in figure 1C should be “Serum sIL6R (ng/mL).” In figure 1E, the y-axis label should be “Serum sgp130 (ng/mL).” In figure 2A, the y-axis label should be “Serum sIL6R (ng/mL).” The editorial office regrets the errors.
- © 2019 American Academy of Neurology
Reference
- 1.↵
- Wosiski-Kuhn M,
- Robinson M,
- Strupe J, et al
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
Alert Me
Recommended articles
-
Article
IL6 receptor358Ala variant and trans-signaling are disease modifiers in amyotrophic lateral sclerosisMarlena Wosiski-Kuhn, Mac Robinson, Jane Strupe et al.Neurology: Neuroimmunology & Neuroinflammation, October 14, 2019 -
Articles
CSF glial markers correlate with survival in amyotrophic lateral sclerosisS. D. Süssmuth, A. D. Sperfeld, A. Hinz et al.Neurology, March 22, 2010 -
Article
Structural and functional brain connectome in motor neuron diseasesA multicenter MRI studySilvia Basaia, Federica Agosta, Camilla Cividini et al.Neurology, September 10, 2020 -
Article
Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosisEmily Feneberg, Patrick Oeckl, Petra Steinacker et al.Neurology, December 06, 2017